Clinical Trial Update: First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 dose-escalation study evaluating safety and immunogenicity of Inventprise's Shigella-04 vaccine in healthy young adults; the trial is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea
• Shigellosis

Drugs mentioned

• Shigella-04 vaccine

Snippet

Sponsor: Inventprise Inc. | Conditions: Shigella, Diarrhea | Phase 1 | Status: RECRUITING